BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Switch Symbol:
Net Income Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-88.88M
↑ 32% above average
Average (9y)
$-130.35M
Historical baseline
Range
High:$-43.02M
Low:$-247.12M
CAGR
+8.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-88.88M | +60.8% |
| 2023 | $-226.54M | +8.3% |
| 2022 | $-247.12M | -34.3% |
| 2021 | $-184.06M | -0.7% |
| 2020 | $-182.81M | -67.9% |
| 2019 | $-108.90M | -7.6% |
| 2018 | $-101.25M | -53.9% |
| 2017 | $-65.78M | -19.3% |
| 2016 | $-55.14M | -28.2% |
| 2015 | $-43.02M | - |